17.33
price up icon5.67%   0.93
after-market Dopo l'orario di chiusura: 17.33
loading
Precedente Chiudi:
$16.40
Aprire:
$16.75
Volume 24 ore:
486.43K
Relative Volume:
1.44
Capitalizzazione di mercato:
$320.52M
Reddito:
$62.81M
Utile/perdita netta:
$-13.75M
Rapporto P/E:
-21.66
EPS:
-0.8
Flusso di cassa netto:
$153.00K
1 W Prestazione:
+38.86%
1M Prestazione:
+36.46%
6M Prestazione:
+175.52%
1 anno Prestazione:
+100.35%
Intervallo 1D:
Value
$16.41
$17.59
Intervallo di 1 settimana:
Value
$12.12
$18.22
Portata 52W:
Value
$3.78
$18.22

Optimizerx Corp Stock (OPRX) Company Profile

Name
Nome
Optimizerx Corp
Name
Telefono
248-651-6558
Name
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Name
Dipendente
129
Name
Cinguettio
@OpRxTweets
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
OPRX's Discussions on Twitter

Confronta OPRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
OPRX
Optimizerx Corp
17.33 300.38M 62.81M -13.75M 153.00K -0.80
Health Information Services icon
VEEV
Veeva Systems Inc
279.18 45.26B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
69.63 10.57B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
64.02 11.58B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
89.27 8.00B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
35.35 6.01B 906.14M -52.62M 89.62M -0.3621

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-08 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-12-20 Iniziato Stephens Equal-Weight
2024-07-25 Ripresa B. Riley Securities Buy
2024-04-04 Iniziato JMP Securities Mkt Outperform
2024-01-03 Iniziato Barclays Equal Weight
2023-02-02 Ripresa B. Riley Securities Buy
2022-11-01 Iniziato Stifel Buy
2022-07-15 Iniziato SVB Leerink Outperform
2021-10-18 Ripresa B. Riley Securities Buy
2021-04-13 Iniziato RBC Capital Mkts Outperform
2019-01-03 Iniziato William Blair Outperform
Mostra tutto

Optimizerx Corp Borsa (OPRX) Ultime notizie

pulisher
12:11 PM

OptimizeRx’s SWOT analysis: digital health firm’s stock faces scaling hurdles - Investing.com

12:11 PM
pulisher
02:18 AM

JMP Securities Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - Defense World

02:18 AM
pulisher
Aug 12, 2025

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 12, 2025
pulisher
Aug 12, 2025

JMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $20.00 - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

Is OptimizeRx Corporation stock bottoming outTechnical Trend Forecast for Investors - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

OptimizeRX price target raised to $20 from $14 at JMP on strong earnings - Investing.com Nigeria

Aug 11, 2025
pulisher
Aug 11, 2025

Will breakout in OptimizeRx Corporation lead to full recoveryReal-Time Signal Tracking with Entry Level - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

What technical models suggest about OptimizeRx Corporation’s comebackDaily Stock Watch Summary with Key Insights - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Can you recover from losses in OptimizeRx CorporationAI Short-Term Gain Forecast with Data - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

What makes OptimizeRx Corporation stock price move sharplySwing Trade Timing with Daily Forecast - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Using AI based signals to follow OptimizeRx CorporationSteady Return Plan Based on Data Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Trend analysis for OptimizeRx Corporation this weekFree Daily Growth Stock Pick Reports - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Should you hold or exit OptimizeRx Corporation nowTechnical Screener for High Growth Stocks - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Blair William & Co. IL Buys 29,648 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat

Aug 10, 2025
pulisher
Aug 10, 2025

Applying Elliott Wave Theory to OptimizeRx CorporationShort Term Gain Strategy with AI Logic - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Stifel Nicolaus Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - MarketBeat

Aug 09, 2025
pulisher
Aug 09, 2025

Advanced analytics toolkit walkthrough for OptimizeRx CorporationTechnical Reversal Pattern Summary and Tracker - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

OptimizeRx Reports Strong Q2 2025 Financial Growth - The Globe and Mail

Aug 09, 2025
pulisher
Aug 08, 2025

Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

OptimizeRx Corp Surpasses Q2 2025 Estimates with 55% Revenue Increase, Achieves GAAP Net Income of $1.5M - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Stifel raises Optimizerx PT to $18, maintains Buy rating. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings call transcript: OptimizeRx Q2 2025 sees EPS surprise, stock jumps - Investing.com Nigeria

Aug 08, 2025
pulisher
Aug 08, 2025

OptimizeRx Corp (OPRX) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Aug 08, 2025
pulisher
Aug 07, 2025

OptimizeRx Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push - inkl

Aug 07, 2025
pulisher
Aug 07, 2025

OPTIMIZERx earnings beat by $0.22, revenue topped estimates - Investing.com

Aug 07, 2025
pulisher
Aug 07, 2025

OptimizeRx Q2 rev up 55% YoY to $29.2mln, raises FY25 guidance. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - The Manila Times

Aug 07, 2025
pulisher
Aug 07, 2025

Press Release: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - 富途牛牛

Aug 07, 2025
pulisher
Aug 07, 2025

Best Growth Stocks to Buy for August 7th - TradingView

Aug 07, 2025
pulisher
Aug 06, 2025

Technical analysis overview for OptimizeRx Corporation stockTrend Reversal Watch with Entry Signals - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Has OptimizeRx Corporation formed a bullish divergenceEntry Opportunity Screener with Confirmation - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

OptimizeRx Corp expected to post earnings of 2 cents a shareEarnings Preview - TradingView

Aug 05, 2025
pulisher
Aug 05, 2025

Best Growth Stocks to Buy for August 5th - TradingView

Aug 05, 2025
pulisher
Aug 04, 2025

OptimizeRx (OPRX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Aug 04, 2025
pulisher
Aug 04, 2025

Is OptimizeRx Corporation stock overvalued or undervaluedExceptional portfolio growth - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

Why is OptimizeRx Corporation stock attracting strong analyst attentionMaximize returns with strategic stock selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is OptimizeRx Corporation stock compared to the marketMaximize returns with timely market signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell OptimizeRx Corporation stock in 2025Get real-time alerts on high-potential stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 01, 2025

Best Growth Stocks to Buy for August 1st - Yahoo Finance

Aug 01, 2025
pulisher
Aug 01, 2025

Published on: 2025-08-01 01:36:35 - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Bull Of The Day: OptimizeRX (OPRX) - The Globe and Mail

Jul 31, 2025
pulisher
Jul 31, 2025

Does OptimizeRx Have a Moat in the Crowded HealthTech Space? - Yahoo Finance

Jul 31, 2025

Optimizerx Corp Azioni (OPRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Optimizerx Corp Azioni (OPRX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Silvestro Stephen L
Chief Commercial Officer
Mar 01 '25
Option Exercise
0.00
1,928
0
121,886
Odence-Ford Marion
Chief Legal Officer & CHRO
Mar 01 '25
Option Exercise
0.00
771
0
70,544
KLEMA CATHY
Director
Feb 02 '25
Option Exercise
0.00
5,109
0
11,752
Odence-Ford Marion
General Counsel and CCO
Dec 19 '24
Option Exercise
0.00
3,927
0
28,383
Silvestro Stephen L
Chief Commercial Officer
Dec 19 '24
Option Exercise
0.00
6,546
0
83,424
Besch Doug
Chief Product Officer
Dec 19 '24
Option Exercise
0.00
1,964
0
12,160
Stelmakh Edward
CFO/COO
Dec 19 '24
Option Exercise
0.00
5,237
0
38,603
FEBBO WILLIAM J
CEO
Dec 12 '24
Buy
5.01
20,000
100,220
601,253
Odence-Ford Marion
General Counsel and CCO
Nov 08 '24
Option Exercise
0.00
1,785
0
24,980
Stelmakh Edward
CFO/COO
Oct 11 '24
Option Exercise
0.00
8,222
0
35,432
$33.24
price up icon 11.17%
$21.02
price up icon 1.50%
$22.39
price up icon 3.13%
$58.05
price up icon 3.68%
$3.24
price up icon 6.58%
health_information_services WAY
$35.35
price up icon 2.23%
Capitalizzazione:     |  Volume (24 ore):